TrialJAMA oncology2020

Efficacy, Safety, and Tolerability of Pertuzumab, Trastuzumab, and Docetaxel for Patients With Early or Locally Advanced ERBB2-Positive Breast Cancer in Asia: The PEONY Phase 3 Randomized Clinical Trial.

Zhimin Shao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.